ACCREDITATION FOR CARDIOVASCULAR EXCELLENCE INC (EIN 261235458) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Phone

8046399213

Tax Period

2023-01-01 to 2023-12-31

ACCREDITATION FOR CARDIOVASCULAR EXCELLENCE INC, founded in 2010, is a small nonprofit in the Medical Research sector that reported $728K in total revenue in fiscal year 2021. Revenue surged 75% from the prior year, signaling strong growth momentum. The organization ran a surplus of $404K, a strong 56% operating margin.

Mission

The organization is a nonprofit whose mission is to ensure high-quality patient care and promote patient safety in facilities where invasive cardiac and endovascular procedures are performed. The organization will achieve its mission by setting standards for quality care establishing requirements for accreditation and providing peer review for cardiac and endovascular programs. The organization will also provide tools and resources to support self evaluation and quality improvement.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $339,930

Investment Income $0

Other Revenue $0

TOTAL REVENUE $339,930

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $252,008

Other Expenses $252,008

TOTAL EXPENSES $252,008

Year-over-Year Comparison

	2023	2022	Change
Revenue	$339,930	$568,149	-0.4%
Expenses	$252,008	$203,248	+0.2%
Net Income	$87,922	$364,901	-0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$20,259

Total Directors

$20,259

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Bonnie Weiner	Chief Medical Officer	5.00	Officer Director	$20,259	$0	$20,259
Jeff Marshall	Director	1.00	Officer Director	$0	$0	$0
Joaquin Cigarroa	Director	1.00	Officer Director	$0	$0	$0
Michael Cowley	Director	1.00	Officer Director	$0	$0	$0
Peggy McElgunn	CEO	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$339,930	$252,008	$800,331	$87,922
2022	$568,149	$203,248	$755,512	$364,901
2021	$727,611	$323,610	$832,987	$404,001

ACCREDITATION FOR CARDIOVASCULAR EXCELLENCE INC